Completed NA INTERVENTIONAL 1-arm NCT02800265

Bioavailability and Mucosal Bioactivity of Avmacol® in Healthy Volunteers

A Pilot Study Evaluating the Bioavailability and Mucosal Bioactivity of the Dietary Supplement, Avmacol®, in Healthy Volunteers With Optimization of Buccal Cell Biomarkers

Sponsor: University of Pittsburgh

Conditions Healthy

Interventions Avmacol

Updated 6 times since 2017 Last updated: Nov 8, 2017 Started: Jun 16, 2016 Primary completion: Jun 20, 2016 Completion: Jun 20, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02800265, this NA trial focuses on Healthy and remains completed. Sponsored by University of Pittsburgh, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Dec 2017 — Jun 2018 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Dec 2017 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.